AVAGEN

Serial Number 88580759
Registration 6493963
700

Registration Progress

Application Filed
Aug 15, 2019
Under Examination
Aug 18, 2020
Approved for Publication
Jun 23, 2020
Published for Opposition
Jun 23, 2020
Registered
Sep 21, 2021

Trademark Image

AVAGEN

Basic Information

Serial Number
88580759
Registration Number
6493963
Filing Date
August 15, 2019
Registration Date
September 21, 2021
Published for Opposition
June 23, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 21, 2021
Registration
Registered
Classes
044

Rights Holder

Avellino Lab USA, Inc.

03
Address
1505 Adams Drive, Suite B2
Menlo Park, CA 94025

Ownership History

Avellino Lab USA, Inc.

Original Applicant
03
Menlo Park, CA

Avellino Lab USA, Inc.

Owner at Publication
03
Menlo Park, CA

Avellino Lab USA, Inc.

Original Registrant
03
Menlo Park, CA

Legal Representation

Attorney
Andrew J. Gray IV

USPTO Deadlines

Next Deadline
783 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-21)
Due Date
September 21, 2027
Grace Period Ends
March 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Sep 5, 2023 NURC C NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Loading...
Aug 3, 2023 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
May 25, 2023 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Dec 13, 2022 PRAM O POST REGISTRATION ACTION MAILED - SEC. 7 Loading...
Dec 6, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 21, 2022 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Sep 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 17, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 14, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 9, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 9, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 29, 2021 IUAF S USE AMENDMENT FILED Loading...
Jul 29, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 5, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 3, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 3, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 3, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 18, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 23, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 23, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 3, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 18, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 16, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 15, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 15, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 15, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 15, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 15, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 14, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 31, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
DNA screening for medical diagnostic purposes * relating to genetic disorders and for eyecare * ; medical information services, namely, providing risk scores and treatment and diagnostic information associated with genes, variants, and mutations associated with eye disease
First Use Anywhere: 20210500
First Use in Commerce: 20210500

Additional Information

Other
In the statement, line 4, "for diagnosing and treating genetic disorders and for eyecare" is inserted. Line 7, "relating to diagnoses and treatment of genetic disorders and for eyecare" is inserted. Line 9, after "purposes", "relating to genetic disorders and for eyecare"

Classification

International Classes
044